NO20065061L - Benzoksazin for behandling av sykdommer i luftveiene - Google Patents

Benzoksazin for behandling av sykdommer i luftveiene

Info

Publication number
NO20065061L
NO20065061L NO20065061A NO20065061A NO20065061L NO 20065061 L NO20065061 L NO 20065061L NO 20065061 A NO20065061 A NO 20065061A NO 20065061 A NO20065061 A NO 20065061A NO 20065061 L NO20065061 L NO 20065061L
Authority
NO
Norway
Prior art keywords
treatment
benzoxazine
respiratory diseases
rog
medicament
Prior art date
Application number
NO20065061A
Other languages
English (en)
Norwegian (no)
Inventor
Kurt Schromm
Christoph Hoenke
Andreas Schnapp
Klaus Rudolf
Ingo Konetzki
Sabine Pestel
Frank Buettner
Hermann Schollenberger
Claudia Heine
Philipp Lustenberger
Thierry Bouyssou
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20065061L publication Critical patent/NO20065061L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20065061A 2004-04-22 2006-11-02 Benzoksazin for behandling av sykdommer i luftveiene NO20065061L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
PCT/EP2005/004075 WO2005102350A1 (fr) 2004-04-22 2005-04-18 Benzoxazines destinees au traitement de maladies des voies respiratoires

Publications (1)

Publication Number Publication Date
NO20065061L true NO20065061L (no) 2006-11-07

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065061A NO20065061L (no) 2004-04-22 2006-11-02 Benzoksazin for behandling av sykdommer i luftveiene

Country Status (20)

Country Link
EP (1) EP1765355B1 (fr)
JP (1) JP2007533684A (fr)
KR (2) KR101338947B1 (fr)
CN (1) CN1946406A (fr)
AU (1) AU2005235420C1 (fr)
BR (1) BRPI0510084A (fr)
CA (1) CA2559700C (fr)
DE (1) DE102004019539A1 (fr)
DK (1) DK1765355T3 (fr)
EA (1) EA012045B1 (fr)
EC (1) ECSP066948A (fr)
ES (1) ES2403184T3 (fr)
IL (1) IL177663A (fr)
NO (1) NO20065061L (fr)
NZ (1) NZ551272A (fr)
PL (1) PL1765355T3 (fr)
SG (1) SG152233A1 (fr)
UA (1) UA85707C2 (fr)
WO (1) WO2005102350A1 (fr)
ZA (1) ZA200606547B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
CA2619402C (fr) 2005-08-15 2015-02-03 Boehringer Ingelheim International Gmbh Procede de production de betamimetiques
EP1948186A1 (fr) * 2005-11-09 2008-07-30 Boehringer Ingelheim International Gmbh Formule aérosol pour inhalation
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
KR20100113557A (ko) 2008-01-11 2010-10-21 노파르티스 아게 키나제 억제제로서의 피리미딘
WO2012034095A1 (fr) 2010-09-09 2012-03-15 Irm Llc Composés et compositions comme inhibiteurs de trk
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
JP5959541B2 (ja) 2011-02-25 2016-08-02 ノバルティス アーゲー Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
WO2014108449A1 (fr) 2013-01-08 2014-07-17 Atrogi Ab Procédé de criblage, trousse, méthode de traitement et composé destinés à être utilisé dans une méthode de traitement
US20200069679A1 (en) 2016-12-12 2020-03-05 Boehringer Ingelheim International Gmbh Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with oladaterol
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
CN120583945A (zh) 2023-01-20 2025-09-02 阿托基公司 用于治疗或预防肌肉消耗的β2-肾上腺素能受体激动剂
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses
GB202403169D0 (en) 2024-03-05 2024-04-17 Atrogi Ab New medical uses
WO2025238248A1 (fr) 2024-05-17 2025-11-20 Atrogi Ab UTILISATION D'AGONISTES DU RÉCEPTEUR β2-ADRÉNERGIQUE DANS LE TRAITEMENT DE L'ATROPHIE MUSCULAIRE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
BR0110331A (pt) * 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
CN1946406A (zh) 2007-04-11
EP1765355B1 (fr) 2013-03-06
JP2007533684A (ja) 2007-11-22
AU2005235420C1 (en) 2011-02-24
IL177663A0 (en) 2006-12-31
CA2559700A1 (fr) 2005-11-03
IL177663A (en) 2014-04-30
AU2005235420A1 (en) 2005-11-03
AU2005235420B2 (en) 2010-10-28
EA012045B1 (ru) 2009-08-28
KR101338947B1 (ko) 2013-12-10
ECSP066948A (es) 2006-12-20
PL1765355T3 (pl) 2013-08-30
WO2005102350A1 (fr) 2005-11-03
ES2403184T3 (es) 2013-05-16
ZA200606547B (en) 2008-04-30
NZ551272A (en) 2010-10-29
BRPI0510084A (pt) 2007-10-16
KR20070054599A (ko) 2007-05-29
SG152233A1 (en) 2009-05-29
EP1765355A1 (fr) 2007-03-28
DK1765355T3 (da) 2013-04-08
CA2559700C (fr) 2013-06-11
KR20130042662A (ko) 2013-04-26
DE102004019539A1 (de) 2005-11-10
EA200601837A1 (ru) 2007-04-27
UA85707C2 (ru) 2009-02-25

Similar Documents

Publication Publication Date Title
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
NO20082496L (no) Pyrazinderivater
ATE369353T1 (de) Medizinisch verwendbare arylethanolamin verbindungen
DE60318193D1 (en) Phenethanolaminderivate
HRP20050432A2 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
WO2002055496A8 (fr) Derives aryle de piperidine et de piperazine comme inducteurs de l'expression du recepteur ldl
GB0112348D0 (en) Compounds
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20062983L (no) Sulfonamid-derivater for behandling av sykdommer
NO20084328L (no) Nye forbindelser
PL1696905T3 (pl) Zastosowanie podstawionych 2-aminotetralin do zapobiegawczego leczenia choroby parkinsona
PL2081910T3 (pl) Nowe związki
WO2009025785A3 (fr) Ligands de récepteur cb2 pour le traitement de la douleur
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
MX2011011618A (es) Agentes terapeuticos 713.
EA200602016A1 (ru) ПОРОШКОВЫЕ КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ЭНАНТИОМЕРНОЧИСТЫЕ β-АГОНИСТЫ
WO2008043788A3 (fr) Nouveaux composés
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application